Stravitz-Sanyal Institute for Liver Disease and Metabolic Health

News

The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints

Tue, Jul 23, '24

BLOG

Sanyal co-authors reporting guidelines for precision medicine research of clinical relevance

Mon, Jul 22, '24

BLOG

New fellows John Grady and Vinay Jahagirdar produce an infographic for Liver Fellow Network

Wed, Jul 17, '24

NEWS

Bajaj: 13% of general population with dementia may have HE instead

Tue, Jul 9, '24

News

GI-Hep program ranked 11th globally

Wed, Jun 26, '24

NEWS

Chief Scientific Officer Saul Karpen's research featured on cover of American Journal of Physiology: Gastrointestinal and Liver Physiology

Fri, Jun 21, '24

EASL News

Director Sanyal announces promising Phase 2 trial results on survodutide

Fri, Jun 7, '24

EASL News

Dr. Bajaj reports success of fecal microbiota transplants in cirrhosis patients

Thu, Jun 6, '24

NEWSLETTER

June 2024 Newsletter

Thu, Jun 6, '24

Publication News

Special issue of the American Journal of Gastroenterology on obesity features op-ed by co-editor Dr. Jasmohan Bajaj

Wed, Jun 5, '24

BLOG

Dr. Sterling reviews the new AASLD practice guidelines on using blood-based and imaging tests

Tue, May 21, '24

NEWSLETTER

May 2024 Newsletter

Mon, Apr 29, '24

VCU NEWS

Liver patients see benefits after going meatless for one meal

Thu, May 2, '24

MCV FOUNDATION

Redefining metabolic health

Thu, May 2, '24

NEWSLETTER

April 2024 Newsletter

Mon, Apr 29, '24

PRESENTATION

Dr. Siddiqui discusses MASH patients post-transplant

Mon, Apr 29, '24

VCU HEALTH

To fight liver disease worldwide, ‘MASH School’ at VCU welcomes Brazilian specialists

Mon, Apr 8, '24

VCU HEALTH

Four Institute Faculty among Richmond Top Docs

Tue, Apr 2, '24

BLOG

Labs and Leadership

Wed, Mar 27, '24

Faculty Honor

Congratulations to Jasmohan Bajaj, M.D., on his election to the American Association of Physicians. Only seven other VCU physicians hold this honor.

Thu, Mar 21, '24

NEWS

Director’s statement on the first drug approved to treat MASH

Thu, Mar 14, '24

Newsletter

March 2024 Newsletter

Thu, Mar 14, '24

NEWS

The Institute welcomes Dr. Saul Karpen as CSO

Mon, Mar 4, '24

Featured

Survodutide, a Glucagon/GLP-1 RA, Reduces MASH in Phase 2 Trial

Tue, Feb 27, '24

Featured

Liver disease MASH is next target for obesity drugs in development

Tue, Feb 27, '24

Video

Jerry Colca of Cirius Therapeutics visits the liver institute

Tue, Feb 20, '24

VCU Health

1 of 10 veterans diagnosed with dementia may instead have cognitive decline from cirrhosis

Wed, Jan 31, '24

VCU News

A student’s interest in liver disease is fueled by his own experience

Wed, Jan 31, '24

Podcast

ACG Clinical Guideline: Alcohol-Associated Liver Disease

Tue, Jan 16, '24

RESEARCH

A milestone in identifying patients at-risk for fatty liver disease

Fri, Jan 12, '24